Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment cancers using a combination comprising PARP inhibitors

US Patent 11202782 · Granted Dec 21, 2021

Estimated economic value: $86,031,000

Assignee

Inventors

View full patent text on Google Patents →